The Additional Value of Free Prostate Specific Antigen to the Battery of Age-Dependent Prostate-Specific Antigen, Prostate-Specific Antigen Density and Velocity

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
Umfang
Online-Ressource

Erschienen in
In: Clinical Chemistry and Laboratory Medicine, Band 35, Ausgabe 6, Seite 475-482, 2009

Ereignis
Veröffentlichung
(wo)
Berlin
(wer)
Humboldt-Universität zu Berlin
(wann)
1997
Urheber
Barak, Mira
Cohen, Michael
Mecz, Yoel
Stein, Avi
Rashkovitzki, Roman
Laver, Benjamin
Lurie, Aharon

DOI
10.1515/cclm.1997.35.6.475
URN
urn:nbn:de:kobv:11-100119910
Rechteinformation
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
14.08.2025, 10:44 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Barak, Mira
  • Cohen, Michael
  • Mecz, Yoel
  • Stein, Avi
  • Rashkovitzki, Roman
  • Laver, Benjamin
  • Lurie, Aharon
  • Humboldt-Universität zu Berlin

Entstanden

  • 1997

Ähnliche Objekte (12)

Biomarkers for prostate cancer: prostate-specific antigen and beyond

Biomarkers for prostate cancer: prostate-specific antigen and beyond

Any decline in prostate-specific antigen levels identifies survivors scheduled for prostate-specific membrane antigen-directed radioligand therapy

Any decline in prostate-specific antigen levels identifies survivors scheduled for prostate-specific membrane antigen-directed radioligand therapy

Any decline in prostate‐specific antigen levels identifies survivors scheduled for prostate‐specific membrane antigen‐directed radioligand therapy

Any decline in prostate‐specific antigen levels identifies survivors scheduled for prostate‐specific membrane antigen‐directed radioligand therapy

Prostate-specific antigen-based screening: controversy and guidelines

Prostate-specific antigen-based screening: controversy and guidelines

Prostate-specific antigen testing accuracy in community practice

Prostate-specific antigen testing accuracy in community practice

Developing new age-specific prostate-specific antigen thresholds for testing for prostate cancer

Developing new age-specific prostate-specific antigen thresholds for testing for prostate cancer

Prostate cancer risk prediction based on clinical factors and prostate-specific antigen

Prostate cancer risk prediction based on clinical factors and prostate-specific antigen

Empirical estimates of prostate cancer overdiagnosis by age and prostate-specific antigen

Empirical estimates of prostate cancer overdiagnosis by age and prostate-specific antigen

Prostate-specific antigen increase after urethral catheterisation: fact or myth

Prostate-specific antigen increase after urethral catheterisation: fact or myth

Biological Half-Life of Prostate-Specific Antigen after Radical Prostatectomy

Biological Half-Life of Prostate-Specific Antigen after Radical Prostatectomy

Some Analytical Considerations on the Measurement of Prostate-Specific Antigen

Some Analytical Considerations on the Measurement of Prostate-Specific Antigen

Local prostate cancer radiotherapy after prostate-specific antigen progression during primary hormonal therapy

Local prostate cancer radiotherapy after prostate-specific antigen progression during primary hormonal therapy

Verbundene Objekte